Insmed
INSM
#752
Rank
โ‚ฌ28.26 B
Marketcap
128,84ย โ‚ฌ
Share price
-2.17%
Change (1 day)
-25.35%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚ฌ0.45 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ1.51 Billion. In 2025 the company made an earning of -โ‚ฌ1.09 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.45 Billion-58.77%
2025 -โ‚ฌ1.09 Billion43.91%
2024 -โ‚ฌ0.76 Billion23.71%
2023 -โ‚ฌ0.62 Billion45.77%
2022 -โ‚ฌ0.42 Billion15.83%
2021 -โ‚ฌ0.37 Billion50.19%
2020 -โ‚ฌ0.25 Billion16.4%
2019 -โ‚ฌ0.21 Billion-23.9%
2018 -โ‚ฌ0.28 Billion59.35%
2017 -โ‚ฌ0.18 Billion8.52%
2016 -โ‚ฌ0.16 Billion47.25%
2015 -โ‚ฌ0.11 Billion34.53%
2014 -โ‚ฌ79.47 Million58.83%
2013 -โ‚ฌ50.03 Million35.14%
2012 -โ‚ฌ37.03 Million-31.92%
2011 -โ‚ฌ54.39 Million854.92%
2010 -โ‚ฌ5.7 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ13.55 Million-27.31%
2007 -โ‚ฌ18.64 Million-62.41%
2006 -โ‚ฌ49.57 Million98.19%
2005 -โ‚ฌ25.01 Million0.03%
2004 -โ‚ฌ25.01 Million159.07%
2003 -โ‚ฌ9.66 Million-69.31%
2002 -โ‚ฌ31.45 Million
2000 -โ‚ฌ28.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ11.52 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚ฌ2.31 Billion 384.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.15 B-973.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ21.19 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚ฌ47.09 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA